MedTrace Logo

An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients

NCT04085445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-12-17

No results posted yet for this study

Summary

To compile the real-world clinical outcome data for the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter (Agent DCB) used in percutaneous coronary intervention (PCI) in Chinese patients.

Conditions

  • Chinese Patients Treated With Agent DCB

Interventions

DEVICE

AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter

To compile the real-world clinical outcome data for the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter (Agent DCB) used in percutaneous coronary intervention (PCI) in Chinese patients.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-13
Primary Completion
2022-08-31
Completion
2024-09-03

Countries

  • Hong Kong
  • Singapore
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04085445 on ClinicalTrials.gov